Aguiar Júnior, P., Barreto, C. M. N., Roitberg, F., Lopes Júnior, G., & del Giglio, A. (2019). Potential life years not saved due to lack of access to anti-EGFR tyrosine kinase inhibitors for lung cancer treatment in the Brazilian public healthcare system: Budget impact and strategies to improve access. A pharmacoeconomic study. São Paulo Medical Journal, 137(6), 505–511. Retrieved from https://periodicosapm.emnuvens.com.br/spmj/article/view/999